HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
The Week

FDA warning slams Zoll Medical with multiple quality control and reporting violations

Zoll Medical, the maker of devices and software focused on cardiopulmonary and respiratory conditions, was slammed in an FDA warning letter that outlined numerous quality control and medical device reporting violations.

By FierceBiotech · Jun 20, 2026 · via FierceBiotech
FDA warning slams Zoll Medical with multiple quality control and reporting violations

Image: FierceBiotech

This is an aggregated industry headline. Read the full story at FierceBiotech →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
Pfizer's CFO Dave Denton will officially depart in August, leaving SVP of finance Cecile Guegan to take up his…
Jun 20, 2026
PwC: Biopharma M&A hits $65B in Q1, marking industry “full health”
The WeekBriefing
PwC: Biopharma M&A hits $65B in Q1, marking industry “full health”
PwC says pharma and life sciences deals topped $65B in Q1 2026, led by big-ticket buys from Sun Pharma and GSK…
Jun 20, 2026
Opinion: STAT readers debate blue zones, open-access publishing fees, and more
The WeekSTAT News ↗
Opinion: STAT readers debate blue zones, open-access publishing fees, and more
Keep those letters coming!…
Jun 20, 2026